跳至主要内容
临床试验/NCT04106765
NCT04106765Unknown不适用

Clinical, EEG and Radiological Initial and Evolutive Characterisation of LGI1-antibody Patients

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 192 人开始时间: 2019年10月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
192
试验地点
1
主要终点
Evolution of epileptic seizures

研究概览

简要总结

Autoimmune encephalitis involve autoantibodies targeting central nervous system, and particularly the synapse or its structure like for LGI1 protein. Anti-LGI1 encephalitis is revealed by an inflammation of the limbic system, with mainly temporal lobe, faciobrachial dystonic or generalized seizures, and cognitive disorders.

This disease is rare and its clinical, EEG and radiological characterisation is not sufficiently established. The investigators will evaluate these three aspects for the anti-LGI1 cohort of patients of the National Reference Center of autoimmune encephalitis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Diagnosis of anti-LGI1 encephalitis based on sera or CSF samples in the National Reference Center of autoimmune encephalitis from 2011/06 to 2019 july 1st.
  • Clinical follow-up in France

排除标准

  • Anti-LGI1 antibody associated with another encephalitis antibody
  • Foreign follow-up

结局指标

主要结局

Evolution of epileptic seizures

时间窗: 12 MONTHS

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

LGI1-antibody Patients Follow-up | 临床试验